FindTrial
Sign In

Comparison of the effectiveness of prolotherapy in sacroiliac joint dysfunction

Comparison of the effectiveness of prolotherapy using 25 percent dextrose versus platelet rich plasma in sacroiliac joint dysfunction syndrome - an observational study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084459
Enrollment
70
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M242- Disorder of ligament

Interventions

Intervention1: group receiving 25% dextrose: One group with sacroiliac joint dysfunction will be receiving 9ml of 25% dextrose to their sacroiliac joint. Then, VAS and ODI will be used to check for th

Sponsors

Dr Lalramthari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with atleast 3 positive provocative test for sacroiliac joint dysfunction 2. 3 months duration or more 3. Failed conservative management

Exclusion criteria

Exclusion criteria: 1. uncontrolled diabetes mellitus 2. pregnancy 3. inflammatory and infectious sacroiliac arthritis 4. on immunosuppresants

Design outcomes

Primary

MeasureTime frame
1. visual analogue scale 2. Oswestry low back pain disability indexTimepoint: from first visit to three months after first injection—

Secondary

MeasureTime frame
demographic profile and clinical features of patientsTimepoint: from first visit to three months—

Countries

India

Contacts

Public ContactDr Roy R Chandran

Government Medical College, Kozhikode

royramachandran@gmail.com9349413831

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026